Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$25.95 - $43.15 $1.15 Million - $1.91 Million
-44,150 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$26.15 - $77.24 $75,835 - $223,995
-2,900 Reduced 6.16%
44,150 $1.27 Million
Q4 2019

Feb 11, 2020

SELL
$60.18 - $154.77 $505,512 - $1.3 Million
-8,400 Reduced 15.15%
47,050 $3.4 Million
Q3 2019

Nov 13, 2019

SELL
$140.29 - $189.96 $782,537 - $1.06 Million
-5,578 Reduced 9.14%
55,450 $7.78 Million
Q2 2019

Aug 01, 2019

SELL
$157.85 - $183.09 $1.09 Million - $1.27 Million
-6,926 Reduced 10.19%
61,028 $0
Q1 2019

May 14, 2019

SELL
$89.33 - $163.65 $1.26 Million - $2.31 Million
-14,136 Reduced 17.22%
67,954 $0
Q4 2018

Feb 07, 2019

BUY
$81.94 - $139.71 $75,138 - $128,114
917 Added 1.13%
82,090 $7.86 Million
Q3 2018

Nov 13, 2018

SELL
$138.11 - $169.04 $1.84 Million - $2.25 Million
-13,300 Reduced 14.08%
81,173 $0
Q2 2018

Jul 18, 2018

BUY
$140.36 - $175.76 $820,684 - $1.03 Million
5,847 Added 6.6%
94,473 $0
Q1 2018

May 01, 2018

BUY
$152.15 - $192.33 $2.54 Million - $3.21 Million
16,687 Added 23.2%
88,626 $0
Q4 2017

Jan 18, 2018

BUY
$60.72 - $167.34 $1.77 Million - $4.87 Million
29,130 Added 68.05%
71,939 $0
Q3 2017

Oct 30, 2017

BUY
$61.4 - $88.52 $2.63 Million - $3.79 Million
42,809
42,809 $0

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $313M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.